Can an open drug discovery model find a solution for rare brain cancers in children? « OICR News

peter.suber's bookmarks 2018-08-01

Summary:

"OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival of less than a year from diagnosis. Finding solutions to this disease is challenging due to its rarity, scientific complexity and its presentation in pediatric populations. An OICR-funded team of researchers, led by Dr. Aled Edwards from M4K Pharma, have developed new potential drug candidates for DIPG that they will test in animal models in the coming months. They’ve reached this milestone ahead of schedule, with fewer resources required than anticipated, by using an ‘open drug discovery’ approach – sharing their methods and data with the greater research community to streamline the drug discovery process...."

Link:

https://news.oicr.on.ca/2018/07/can-an-open-drug-discovery-model-find-a-solution-for-rare-brain-cancers-in-children/

From feeds:

Open Access Tracking Project (OATP) » peter.suber's bookmarks
Open Access Tracking Project (OATP) » ab1630's bookmarks

Tags:

oa.new oa.clinical_trials oa.open_science oa.stem oa.data oa.speed oa.neuro oa.medicine oa.pharma

Date tagged:

08/01/2018, 18:35

Date published:

08/01/2018, 08:31